AI news story

US Department of Justice backs fair use for AI training in landmark copyright case

In the class-action lawsuit involving The New York Times, the US Department of Justice argues that training AI models on copyrighted text qualifies as fair use. The filing directly contradicts a report from the US Copyright Office. Its director was f

  • AI
  • Source: The Decoder
  • Published: 2026-09-02
  • Signal score: 5
  • 2 sources

Editor's take

The Department of Justice has formally asserted that training AI models on copyrighted material constitutes fair use, a stance directly at odds with the US Copyright Office's recent findings. This intervention in the class-action lawsuit brought by The New York Times and other publishers against OpenAI and Microsoft introduces significant legal uncertainty into the burgeoning generative AI industry.

The implications are substantial. If the DOJ's argument prevails, it could significantly lower the legal hurdles for AI developers seeking to build powerful models by accessing vast datasets of existing text and images, potentially accelerating innovation but also raising concerns for content creators whose work fuels these systems without direct compensation. This legal battle will shape the economic models underpinning AI development for years to come.

Future attention should focus on how courts will reconcile the DOJ's position with the Copyright Office's report, and whether legislative action becomes necessary. The outcome could dictate whether AI companies must pursue licensing agreements for training data or if the fair use doctrine provides a sufficient shield, impacting the financial viability of numerous AI startups and established tech giants alike.

Signal score: 5

This event was corroborated by 2 independent sources. The signal score weighs cross-source corroboration, recency, source weight and topic salience. How we rank stories.

More AI stories

  1. AI-Discovered Drug Reverses Aging Markers in Study, Biotech Says

    Bloomberg · 2026-09-07

    An experimental lung disease drug developed using artificial intelligence showed promise in reversing biological signs of aging, pointing to broader potential use of the treatment

  2. US Tech Firms Eye Australia for AI Centers, Local Operator Says

    Bloomberg · 2026-09-07

    US tech titans are interested in building data centers in Australia, drawn by its green grid and proximity to Asia, as they face a growing backlash at home

  3. Malaysia Eyes Huawei Chips for AI Project Despite US Warning

    Bloomberg · 2026-09-07

    Malaysia is leaning toward relying on Huawei Technologies Co.’s artificial intelligence chips to power its sovereign AI efforts

  4. I refused to train the AI that could replace me

    Hacker News · 2026-09-07

    A former AI trainer declined to label data for a model that could automate her own job, highlighting a growing tension in the AI development pipeline.

  5. The Great Bifurcation: Two Races, One AI Future

    Towards AI · 2026-09-07

    The narrative of a single, unified race toward Artificial General Intelligence (AGI) is obsolete. In its place, the AI landscape has…

  6. OpenWiki In Production: A Realistic Setup & Review Guide

    Towards AI · 2026-09-07

    Make your codebase AI-ready with OpenWiki. A pragmatic practitioner’s guide to bounding agent reads, tracking costs, and reviewing PRs.